Zai Lab (ZLAB) Non-Current Deffered Revenue (2016 - 2026)

Zai Lab's (ZLAB) quarterly Non-Current Deffered Revenue came in at $28.6 million in Q1 2026, down 4.98% year-on-year from $30.1 million in Q1 2025, and up 4.73% quarter-over-quarter from $27.3 million in Q4 2025.

Zai Lab (ZLAB) Non-Current Deffered Revenue (2016 - 2026) Analysis & Trends

Zai Lab has disclosed Non-Current Deffered Revenue across 8 years of filings, most recently posting $28.6 million for Q1 2026.

  • Non-Current Deffered Revenue for Q1 2026 came in at $28.6 million, down 4.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $28.6 million (down 4.98% YoY), and the FY2025 annual result was $27.3 million, down 13.04% from the prior year.
  • Non-Current Deffered Revenue came in at $28.6 million for Q1 2026 at Zai Lab, up from $27.3 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $31.4 million in Q4 2024 to a low of $21.4 million in Q4 2022.
  • The 5-year median for Non-Current Deffered Revenue is $27.9 million (2023), against an average of $27.3 million.
  • Across the five-year window, Non-Current Deffered Revenue dropped 22.29% in 2022 and surged 34.54% in 2023, its largest moves.
  • Zai Lab's Non-Current Deffered Revenue stood at $21.4 million in 2022, then soared by 34.54% to $28.7 million in 2023, then gained by 9.38% to $31.4 million in 2024, then decreased by 13.04% to $27.3 million in 2025, then climbed by 4.73% to $28.6 million in 2026.
  • The last three Non-Current Deffered Revenue figures came in at $28.6 million (Q1 2026), $27.3 million (Q4 2025), and $28.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Zai Lab 20.15 Bn 20.05 Bn 61.30 Mn 28.63 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 28.63 Mn
Dec 31, 2025 27.33 Mn
Sep 30, 2025 28.06 Mn
Jun 30, 2025 29.23 Mn
Mar 31, 2025 30.13 Mn
Dec 31, 2024 31.43 Mn
Sep 30, 2024 24.92 Mn
Jun 30, 2024 25.34 Mn
Mar 31, 2024 26.30 Mn
Dec 31, 2023 28.74 Mn
Sep 30, 2023 27.69 Mn
Jun 30, 2023 28.63 Mn
Mar 31, 2023 30.97 Mn
Dec 31, 2022 21.36 Mn
Sep 30, 2022 23.21 Mn
Jun 30, 2022 24.78 Mn
Dec 31, 2021 27.49 Mn
Dec 31, 2017 2.39 Mn
Dec 31, 2016 778,434.00